Daily feed · SEC Form 4 filings
Insider buying in low-priced stocks — Oct 31, 2017
Open-market purchases where the filing’s own weighted average price is under $5. Price comes from the Form 4 itself, not a market quote.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2017 PForm 4 → | Oct 30, 5:12 pm EDT | IDERA PHARMACEUTICALS, INC.IDRA | BAKER BROS. ADVISORS LP +6Director | 8,000,000 | $1.50 | $12,000,000 | 16,557,473 | +93.5% | plan? |
| Oct 27, 2017 PForm 4 → | Oct 30, 5:03 pm EDT | Immune Design Corp.IMDZ | COLUMN GROUP L P +710% Owner | 2,681,000 | $4.10 | $10,992,100 | 6,642,942 | +67.7% | plan? |
| Oct 26, 2017 PForm 4 → | Oct 30, 4:11 pm EDT | VBI Vaccines Inc/BCVBIV | PERCEPTIVE ADVISORS LLC +210% Owner | 3,100,000 | $3.05 | $9,455,000 | 9,345,725 | +49.6% | plan? |
| Oct 27, 2017 PForm 4 → | Oct 30, 7:30 pm EDT | SUNESIS PHARMACEUTICALS INCSNSS | Dayton MisfeldtDirector | 400,000 | $2.00 | $800,000 | 30,456 | — | plan? |
| Oct 27, 2017 PForm 4/A → | Oct 31, 10:08 am EDT | AGENUS INCAGEN | Garo H ArmenChairman & CEO | 100,000 | $3.55 | $355,115 | 1,590,441 | +6.71% | plan? |
| Oct 27, 2017 PForm 4 → | Oct 30, 5:01 pm EDT | RETRACTABLE TECHNOLOGIES INCRVP | Thomas J ShawPresident and CEO, Director, 10% Owner | 25,887 | $0.6564 | $16,992 | 13,178,129 | +0.20% | plan? |
| Oct 27, 2017 PForm 4 → | Oct 31, 3:10 pm EDT | ENDONOVO THERAPEUTICS, INC.ENDV | Michael Scott MannPresident, 10% Owner | 13,000 | $0.0614 | $798 | 24,035,189 | +0.05% | plan? |
| Oct 30, 2017 PForm 4 → | Oct 31, 10:44 am EDT | NOCOPI TECHNOLOGIES INC/MD/NNUP | Philip WhiteDirector | 12,500 | $0.039 | $488 | 294,245 | +4.44% | plan? |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.